Skip to main content
Premium Trial:

Request an Annual Quote

Kreatech Biotechnology, Agilent Technologies

Premium
Kreatech Biotechnology this week said that its aRNA labeling kits and RNA ampULSe amplification and labeling kits are now available for specific use on the Agilent microarrays platform.
 
In addition Kreatech has made available one-color formats with either Cy3 or Cy5 options for the user.

 


 

Agilent Technologies this week announced the availability of 244,000 feature chromatin immunoprecipitation (ChIP)-on-chip microarrays.

 
The new chips contain six times as many features as the company’s debut ChIP-on-chip arrays and can be used in tiling array experiments, Agilent said.
 
The upgrade is part of a density increase that is affecting all of Agilent’s microarray products (see BAN 7/11/2006).

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.